Steady-state clearance rates of warfarin and its enantiomers in therapeutically dosed patients

Chirality

Volumn 9, Issue 1, 1997, Pages 13-16

  McAleer, Sarah D ^a   Foondun, Aboo S ^b   Feely, Morgan ^b   Chrystyn, Henry ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

AUC data; patients; R warfarin; S warfarin; steady state clearance

Indexed keywords

WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; AREA UNDER THE CURVE; ARTICLE; CHIRAL CHROMATOGRAPHY; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG CLEARANCE; ENANTIOMER; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RACEMIC MIXTURE; STEADY STATE;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; STEREOISOMERISM; WARFARIN;

EID: 0030888416     PISSN: 08990042     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-636X(1997)9:1<13::AID-CHIR3>3.0.CO;2-H     Document Type: Article

References (15)

1. Hewick, D.S., McEwen, J. Plasma half-lives, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man. J. Pharm. Pharmacol. 25(6):458-465, 1973.
2. Breckenridge, A., Orme, M., Wesseling, H., Lewis, R.J., Gibbons, R. Pharmacokinetics and pharmacodynamics of the enantiomers of warfarin in man. Clin. Pharmacol. Ther. 15(4):424-430, 1974.
3. Lewis, R.J., Trager, W.F. Warfarin metabolism in man: Identification of metabolites in urine. J. Clin. Invest. 49:907-913, 1970.
4. Lewis, R.J., Trager, W.F., Chan, K.K., Breckenridge, A., Orme, M., Rowland, M., Schary, W. Warfarin: Stereochemical aspects of its metabolism and the interaction with phenylbutazone. J. Clin. Invest. 53:1607-1617, 1970.
5. Chan, K.K., Lewis, R.J., Trager, W.F. Absolute configurations of the four warfarin alcohols. J. Med. Chem. 15(12):1265-1270, 1972.
6. O'Reilly, R.A. Studies on the optical enantiomorphs of warfarin in man. Clin. Pharmacol. Ther. 16(2):348-354, 1974.
7. Wingard, L.B., O'Reilly, R.A., Levy, G. Pharmacokinetics of warfarin enantiomers: A search for intrasubject correlations. Clin. Pharmacol. Ther. 23(2):212-217, 1978.
8. Hignite, C., Uetrecht, J., Tschanz, C., Azarnoff, D. Kinetics of R- and S-warfarin isomers. Clin. Pharmacol. Ther. 8(1):99-105, 1980.
9. Banfield, C., Rowland, M. Stereospecific high-performance liquid chromatographic analysis of warfarin and its metabolites in plasma and urine. J. Pharm. Sci. 73:1392-1396, 1985.
10. Toon, S., Holt, B.L., Mullins, G.F.P., Bullinham, R. Aarons, L., Rowland, M. Investigations into the potential effects of multiple dose keterolac on the pharmacokinetics and pharmacodynamics of racemic warfarin. Br. J. Clin. Pharmacol. 30:743-750, 1990.
11. Hallack, H.U., Wedlund, P.J., Modi, M.W., Patel, H., Lewis, G.L., Woodruff, B., Trowbridge, A.A. High clearance of S-warfarin in a warfarin-resistant subject. Br. J. Clin. Pharmacol. 35:327-330, 1993.
12. Chu, Y.U., Wainer, I.W. The measurement of warfarin enantiomers in serum using coupled achiral/chiral high performance liquid chromatography (HPLC). Pharm. Res. 5:680-683, 1988.
13. Chan, E., McLachlan, A.J., Pegg, M., Mackay, A.D., Cole, R.B., Rowland, M. Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin. Br. J. Clin. Pharmacol. 37:536-569, 1994.
14. McAleer, S.D., Chrystyn, H., Foondun, A.S. Measurement of the (R) and (S) isomers of warfarin in patients undergoing anticoagulant therapy. Chirality 4:488-493, 1992.
15. Allard, S., Peaker, S., Roberts, B.E., Davies, J.A., Feely, M.P. Patient compliance and control of anticoagulation with warfarin. Br. J. Haematol. 77(Suppl):P148, 1991.